Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:968-974
Published online before print January 28, 2002, doi: 10.1161/hc0802.104324
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/8/968    most recent
hc0802.104324v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cuda, G.
Right arrow Articles by Avvedimento, E. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cuda, G.
Right arrow Articles by Avvedimento, E. V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-METHIONINE
*HYDROGEN PEROXIDE
Related Collections
Right arrow Oxidant stress

(Circulation. 2002;105:968.)
© 2002 American Heart Association, Inc.


Basic Science Reports

Protection of Human Endothelial Cells From Oxidative Stress

Role of Ras-ERK1/2 Signaling

Giovanni Cuda, MD*; Roberto Paternò, MD*; Roberto Ceravolo, MD; Mafalda Candigliota, MD; Nicola Perrotti, MD; Francesco Perticone, MD; Maria Concetta Faniello, PhD; Filippo Schepis, MD; Antonio Ruocco, MD; Evelina Mele, PhD; S. Cassano, PhD; Maurizio Bifulco, MD; Mariarosaria Santillo, PhD; Enrico V. Avvedimento, MD

From the Dipartimento di Medicina Sperimentale e Clinica "G. Salvatore" (G.C., R.C., M.C., N.P., F.P., M.C.F., F.S., E.M., M.B, E.V.A.), Università di Catanzaro "Magna Graecia," and Dipartimento di Biologia e Patologia Cellulare e Molecolare (E.V.A.), Centro di Endocrinologia ed Oncologia Sperimentale del CNR (E.V.A., S.C.), Dipartimento di Medicina Clinica e Sperimentale (R.P., A.R.), and Dipartimento di Neuroscienze e Scienze del Comportamento Sezione di Fisiologia (M.S.), Università Federico II, Napoli, Italy.

Correspondence to Dr Enrico V. Avvedimento, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Centro di Endocrinologia ed Oncologia Sperimentale del CNR, via S. Pansini, 5 80131 Napoli, Italy. E-mail avvedim{at}unina.it


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background Reactive oxygen species play a critical role in inducing apoptosis. The small GTPase p21 Ras and the ERK1/2 MAPK have been proposed as key regulators of the signaling cascade triggered by oxidative stress (H2O2). Harvey-Ras (Ha-Ras) and Kirsten-Ras (Ki-Ras) isoforms are so far functionally indistinguishable, because they activate the same downstream effectors, including ERK1/2. Moreover, ERK1/2 signaling has been involved in both protection and induction of apoptosis.

Methods and Results Human umbilical vein endothelial cells (HUVECs) were subjected to H2O2, and apoptosis was detected by fluorescence-activated cell sorting analysis, fluorescence microscopy, and caspase-3 activation. Transfection of Ha-Ras and Ki-Ras genes in HUVECs was performed to evaluate the response to H2O2. We have found that, whereas Ha-Ras decreases tolerance to oxidative stress, Ki-Ras has a potent antiapoptotic activity. Both effects are mediated by ERK1/2. Tolerance to H2O2 is encoded by a unique stretch of lysines at the COOH terminus of the Ki-Ras, lacking in Ha-Ras, and it is relatively independent of the farnesylated anchor. Inhibition of p21 Ras signaling by farnesylation inhibitors increased the resistance to apoptosis in Ha-Ras–expressing cells.

Conclusions These findings explain the opposite effects of ERK1/2 stimulation on apoptosis found in different cell types and suggest that local activation of ERK1/2 signaling may account for the opposing response to oxidative stress by Ha-Ras or Ki-Ras–expressing cells. Modulation of cell reactivity to oxidative stress by p21 Ras points to the specific and predictive effects of Ras inhibitors in vivo as potential therapeutic drugs in disorders produced by increase of reactive oxygen species inside the cells.


Key Words: endothelium • apoptosis • stress • free radicals • hypoxia


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
High reactive oxygen species (ROS) levels have been detected in several human disorders such as neurodegenerative diseases, cancer, ischemia, atherosclerosis, and aging.15 A growing body of evidence suggests that the small GTPase p21 Ras is an essential mediator of the signal transduction pathway leading to cell apoptosis after oxidative injury.68

Oxidative stress and p21 Ras activate a group of kinases, the mitogen-activated protein kinase (MAPK) family,9 including the extracellular signal–regulated kinases (ERK1/2), c-Jun NH2-terminal kinase (JNK or SAPK), and p38 MAPK.10

ERK1/2 signaling has been involved both in protection11,12 and induction13,14 of apoptosis. To date this paradoxical effect(s) has not been fully understood. To address this question, we have explored the biological activity of different isoforms of p21 Ras. The 3 major isoforms of this small GTPase protein are N-Ras, Kirsten Ras (Ki-Ras), and Harvey Ras (Ha-Ras). Specifically, Ki-Ras and Ha-Ras share a high degree of structural and functional homology. Both Ras proteins are farnesylated and localized in the inner face of the plasma membrane.15 The sequences of Ki-Ras and Ha-Ras proteins are almost identical. They diverge only in the 20–amino acid hypervariable domain at the COOH termini. Although their functions remain indistinguishable,16 very recently, evidence for differential activities of the Ras isoforms has started to accumulate.17 We have found recently that the effects of Ha-Ras and Ki-Ras on ROS levels are complementary; Ha-Ras activates, and Ki-Ras reduces, intracellular ROS.18,19

In the present study, we show that Ha-Ras protein increases the number of cells undergoing apoptosis after oxidative stress; conversely, the Ki-Ras isoform has a protective effect, encoded by a polybasic stretch of lysine residues at the COOH terminus of the molecule, not present in the Ha-Ras sequence.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Cells
HUVECs from American Type Culture Collection were maintained in RPMI 1640 (Life Technologies) with 10% FBS (Life Technologies) and 2 mmol/L glutamine, and were used at passages 5 to 10.

Plasmids and Transfections
Bicistronic vectors (pIRES) were used for expressing Ha-Ras, Ki-Ras, and green fluorescent protein (GFP) genes under the control of the cytomegalovirus promoter (Clontech), as follows: (1) V12 human Ha-Ras cDNA cleaved with BamHI and EcoRI was inserted into the GFP vector (2.1) cleaved with BglII-EcoRI, and (2) V12 human Ki-Ras 4B cDNA cleaved with BamHI-XhoI was inserted into the GFP vector (2.2) cleaved with BglII-XhoI. The constructs were verified by DNA sequence analysis.

The Ki-Ras mutants were generated by PCR using a Ki-specific 5' primer and 3 different 3' primers. The template was the pGEM3Z–Ki-Ras containing the sequence encoding human Ki-Ras 4B (valine 12) protein as reported in the GenBank databases (HUMKRASM bases 193 to 759). The 5' primer was 5TKRAS, as follows: 5'-GATCGGATCCATGGACTACAAGGACGACGATGACAAGA-TGACTGAATATAAACTTGTGG-3'. The sequence included the following: (1) 4 nonspecific bases (GATC), (2) a BamHI site, (3) an ATG start, (4) 24 bases encoding a methionine residue and a hemoagglutinin tag (DYKDDDDK), and (5) 22 bases encoding the N terminus of the wild-type protein (MTEYKLV).

The three 3' primers were the following: (1) NOLISNOCIS (Cis-Lys-) (mutation of the cysteine of the CAAX box and of the lysines of the polybasic stretch), 5'-GATCCTCGAGTTACATAAT-TACAGCCTTTGTCTTTGACTCCTCTTCCTCCTTTTTACCATC-3'; (2) NOLIS (Lys-) (mutation in the lysines of the polybasic stretch), 5'-GATCCTCGAGTTACATAATTACACACTTTGTCTTTGACTCC-TCTTCCTCCTTTTTACCATC-3'; and (3) NOCIS (Cis-) (mutation in the cysteine of the CAAX box), 5'-GATCCTCGAGTTACATAA-TTACAGCCTTTGTCTTTGAC-3'. The 3' primers included 4 nonspecific bases (GATC) and an XhoI site. Specifically, the NOLISNOCIS primer encodes the last 16 amino acids of the Ki-Ras protein, in which the KKKK (amino acids 175 to 179) was mutated to EEEE and C 185 was mutated to A. In the 3'-NOLIS primer, only the KKKK (amino acids 175 to 179) was mutated to EEEE. In the 3'-NOCIS primer, only the C 185 was mutated to A.

The 3 PCR products were cut with BamHI and XhoI and subcloned in the BglII-XhoI sites of pGFP/IRES 2.2 plasmid. The constructs were then confirmed by sequencing. The nonmutated sequence was similarly cloned with a 3'-end primer without mutations. The mutants and wild-type constructs were transfected in COS7 and HUVECs. Ras proteins were analyzed by immunoblot and Raf-1 binding. We have noticed that the native methionine start codon was more efficiently translated than the synthetic codon of the HA tag at the N-terminus of Ras proteins.

The vector carrying Rous sarcoma virus (RSV) promoter driving the Ha-Ras mutant (Leu61-Ser186) was constructed by insertion of the plasmid pZIP Ha-Ras (Leu61-Ser186) coding region (1.2-kb BamHI fragment) into the polylinker of pRSV.20 Ki-Ras/GFP fusion protein was obtained by ligating the Ki-Ras 2B EcoRI-BamHI fragment (49 amino acids at the COOH terminus) with the EGFP-C3 vector (Clontech) cleaved with EcoRI and BamHI. Ha-Ras/GFP fusion protein was obtained by ligating the Ha-Ras AviII-EcoRI fragment (90 amino acids at the COOH terminus) with the EGFP-C3 vector cleaved with ScaI and EcoRI.

Cells were transiently transfected using the FuGENE-6 reagent (Roche). After 24 hours, the cells were then processed for fluorescence microscopy, fluorescence-activated cell sorting (FACS) analysis, or biochemical assays.

Apoptosis Assays
Apoptosis in vitro was assayed by 3 distinct approaches. HUVECs were grown to 70% to 80% confluence and treated for 2 hours with 2 mmol/L H2O2. When needed, cells were preincubated overnight with PD98059 (40 µmol/L) (Calbiochem) or FTI-277 (20 µmol/L) (Calbiochem). Six hours after the removal of the stimulus, apoptosis was detected either by fluorescence microscopy or FACS analysis (FACSCalibur) using propidium iodide (PI) or annexin V (Clontech). To measure caspase-3 activity, cells were cultured under the same conditions. After oxidative injury, cells were collected and lysed in appropriate buffer. Total cell extract (30 to 50 µg) was electrophoresed onto a 12.5% SDS-PAGE and transferred to polyvinylidene difluoride membrane (Millipore). The blot was incubated with a polyclonal anti–caspase-3 antibody (BD-PharMingen), and the presence of total and active caspase-3 was revealed by chemiluminescence (Amersham-Pharmacia Biotech).

The concentration and the exposure time to H2O2 were selected by determining dose-response and time curves. Under these conditions, the assay was linearly dependent on H2O2 concentration and incubation time. Longer incubation periods or higher concentrations of H2O2 resulted in massive apoptosis, and the difference in the cytoprotection between Ha-Ras– and Ki-Ras–expressing cells was abolished.

Biochemical Assays
For Western blotting with the antibodies against the phosphorylated form of ERK1/2 and JNK, HUVECs were grown to confluence, lysed in radioimmunoprecipitation assay buffer, separated by a 12.5% SDS-PAGE, and immunoblotted with a monoclonal anti–phospho-ERK1/2 or anti–phospho-JNK (New England BioLabs). After being "stripped," the membranes were reprobed with polyclonal antibodies against the total (phosphorylated and unphosphorylated) ERK1/2 and JNK (Santa Cruz Biotechnology).

For immunodetection of Ha-Ras and Ki-Ras, cells were lysed in Triton buffer (1% Triton X-100 and (in mmol/L) NaCl 150, Tris-HCl [pH 7.5] 20, and EDTA 2) supplemented with protease inhibitors; lysates were cleared by centrifugation and incubated overnight at 4°C with a polyclonal anti–pan-Ras antibody (Santa Cruz Biotechnology), followed by a 1-hour incubation at 4°C with protein G beads. The immunoprecipitates were washed 3 times with washing buffer (50 mmol/L Tris-HCl, pH 7.5), centrifuged, and resuspended in 5x SDS sample buffer. Blots were developed with specific monoclonal antibodies against Ha-Ras and Ki-Ras (Santa Cruz Biotechnology).

ROS levels were determined by 2',7'-dichlorofluorescin fluorescence using the oxidation-sensitive probe, 5,6-carboxy–2',7'-dichlorofluorescein diacetate.19

Statistical Analysis
All data are shown as mean±SEM. Statistical analysis between groups was performed according to the {chi}2 test. A P value <0.05 was considered significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Oxidative Stress Induces Apoptosis in Endothelial Cells
HUVECs were stimulated for 2 hours with 2 mmol/L H2O2. After the removal of the oxidative stress, the cells were incubated in the normal medium and apoptosis was determined as described in Methods. Figure 1a shows that 6 hours after the removal of oxidative stimulus, the fraction of apoptotic cells significantly increased. Later (24 hours), the nuclei of apoptotic cells stained with PI. Apoptosis was monitored also by determining the activation of caspase-3 (Figure 1b). 21 The ratio between the 33-kDa procaspase-3 and the 17-kDa active caspase-3 is a measure of apoptosis induced by H2O2. The histogram in Figure 1b shows a significant accumulation of active caspase-3 in H2O2-treated cells.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 1. Oxidative stress induces apoptosis in endothelial cells. HUVECs were stimulated with H2O2 and apoptosis was detected by fluorescence microscopy as described in Methods. a, Time course of annexin V–FITC (closed symbols) and PI (open symbols) fluorescence in the presence ({triangleup} and {blacktriangleup}) or absence ({circ} and {bullet}) of oxidative injury. b, Immunoblot developed with a polyclonal antibody against caspase-3 in the presence or absence of H2O2 stimulation. Diagram shows densitometric analysis of active caspase-3. AU indicates arbitrary units. c, Time course of stress-kinase activation after oxidative injury. Immunoblot developed with antibodies against the active, phosphorylated, and total forms of ERK1/2 and JNK. Diagram below figure shows relative quantification by densitometric analysis. All data are mean±SEM of 3 independent experiments.

The molecular signaling of oxidative stress was investigated by determining the activation of stress-related kinases.

HUVECs were stimulated with 2 mmol/L H2O2 for 10, 20, 30, and 60 minutes, and the lysates were probed with specific anti–phospho-ERK1/2 and anti–phospho-JNK antibodies. Figure 1c shows the activation pattern of the 2 kinases. Although ERK1/2 activation appears to be stronger than that of JNK, both kinases reach the maximal peak at the 20-minute time point, suggesting a common mechanism of activation. Note that these are early events in the apoptotic process (compare Figure 1a and 1b). The activation of stress kinases and the onset of apoptosis were inhibited by 30 mmol/L of the reducing agent N-acetyl cysteine (data not shown).

Ha-Ras Amplifies, and Ki-Ras Inhibits, H2O2-Induced Apoptosis
Because stress-activated kinases are regulated by p21 Ras, we have tested whether expression of Ras influences the response to oxidative stress. HUVECs grown on coverslip slides were transiently transfected with either the Ki-Ras– or Ha-Ras–expressing vectors. Transfection efficiency was evaluated by determining the number of the cells expressing the GFP encoded by the same polycistronic mRNA (see Methods). After stimulation with H2O2, the oxidative stress was removed and the apoptosis was detected 6 hours later by fluorescence microscopy (Figure 2a). Cells overexpressing Ha-Ras gene (green) showed a higher degree of PI staining (yellow) compared with mock-transfected cells, suggesting a proapoptotic effect of the p21 Ha-Ras protein. Conversely, a significant decrease in PI staining was detected in Ki-Ras–transfected endothelial cells, indicating a protective role of the Ki-Ras gene product on oxidative stress–induced apoptosis. To obtain quantitative data of these Ras effects on H2O2-induced apoptosis, we carried out FACS analysis of Ras-transfected cells by using annexin V–cy3 (red). Figure 2b shows that FACS analysis confirms microscopy data.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 2. Ha-Ras amplifies and Ki-Ras inhibits H2O2-induced apoptosis. a, HUVECs transfected with Ha-Ras and Ki-Ras pIRES plasmids were subjected to oxidative injury. Apoptotic cells are shown by PI staining (red). Yellow cells derive from the overlay of green (GFP) and red (PI) fluorescence. Red cells are untransfected HUVECs undergoing apoptosis. b, FACS analysis of Ha-Ras– and Ki-Ras–expressing cells (described in panel a) stained with annexin V–cy3 (red) in the presence or absence of the MEK inhibitor PD98059 (40 µmol/L, 18 hours). Cotransfection of Ha-Ras– or Ki-Ras–expressing cells with the dominant negative Leu61-Ser186 Ras reversed the pro- and antiapoptotic effects of the 2 Ras genes. Histograms represent the percentage of annexin V–positive cells, determined in 3 independent experiments. All data are mean±SEM. *P<0.05 vs control; **P<0.05 vs Ha-Ras or Ki-Ras controls.

Induction (Ha-Ras) and Inhibition (Ki-Ras) of H2O2-Induced Apoptosis Are Mediated by ERK1/2 Signaling
To demonstrate the specificity of Ras-elicited effects, the dominant negative Leu61-Ser186 Ras gene, which sequesters upstream and downstream p21 Ras effectors,22 was cotransfected in either the Ha-Ras– or Ki-Ras–expressing HUVECs. Figure 2b shows that both the potentiating effect of Ha-Ras and the inhibitory action of Ki-Ras on H2O2-induced apoptosis were abolished by Leu61-Ser186 Ras. To determine the effector(s) downstream Ras, we pretreated Ha- or Ki-expressing cells with PD98059, a specific MEK inhibitor.23 Both Ha-Ras and Ki-Ras effects were suppressed by PD98059, replicating the inhibition induced by Leu61-Ser186 (Figure 2b). Under the same conditions, JNK and p38 MAPK activities were not affected (data not shown).

To rule out the effects caused by overexpression of Ras exogenous gene(s), we sought to determine whether the endogenous Ras was also able to modulate H2O2-induced apoptosis. We first analyzed the expression pattern of Ras genes in HUVECs and then measured the sensitivity of the cells to H2O2. Figure 3 shows that (1) Ha-Ras was the predominant isoform expressed by these cells (Figure 3a); (2) H2O2-induced activation of stress kinases was affected by FTI-277, a farnesyl transferase inhibitor20 (Figure 3b); and (3) oxidative stress–induced apoptosis was reversed by PD98059 or by FTI-277 (Figure 3c and 3d). The 2 compounds showed a comparable degree of inhibition of caspase-3 activation and apoptosis, although FTI-277 inhibited both ERK1/2 and JNK, whereas PD98059 prevented only ERK1/2 activation (data not shown). Taken together, these data indicate that Ha-Ras and ERK1/2, but not JNK signaling, are necessary for oxidative stress–induced apoptosis in endothelial cells (Figures 2b, 3c, and 3d).



View larger version (47K):
[in this window]
[in a new window]
 
Figure 3. Expression of Ha-Ras and Ki-Ras and modulation of p21 Ras signaling in HUVECs. a, Immunoblot developed with monoclonal antibodies against Ha-Ras and Ki-Ras on cell lysates previously immunoprecipitated with a polyclonal anti–pan-Ras antibody. A polyclonal antibody against ERK1/2 was used to normalize the amount of protein loaded. b, Time course of stress-kinase activation after oxidative injury in the absence or presence of FTI-277. Immunoblots were developed with monoclonal antibodies against the active, phosphorylated forms of ERK1/2 and JNK. c, Immunoblot developed with a polyclonal antibody against caspase-3 in cell lysates in the absence (control) or presence of the MEK inhibitor PD98059 and the farnesylation inhibitor FTI-277. Cells were stimulated with H2O2. d, Histograms represent percentage of annexin V-cy3–positive cells (mean±SEM), in the absence (control) or presence of PD98059 and FTI-277 as determined in 3 independent experiments by fluorescence microscopy.

Molecular Determinants Underlying Ki-Ras Tolerance to Oxidative Stress
To identify the molecular determinants that mediate the inhibition of H2O2-induced apoptosis by Ki-Ras, we mutagenized the lysine residues of the polybasic region of Ki-Ras to glutamic acid (Lys-) or the cysteine of the CAAX farnesylation box (shared by both Ki-Ras and Ha-Ras isoforms) to alanine (Cys-) or both (Lys-/Cys-). The mutants were expressed in HUVECs, and the tolerance of the cells to oxidative stress was measured.

H2O2-induced apoptosis was significantly affected in cells expressing Ki-Ras mutants (Figure 4a); specifically, Cys- Ki-Ras partially reduced tolerance to oxidative injury compared with Ki-Ras wild type–expressing cells, whereas a significant increase in apoptosis was observed in Lys- mutant transfected cells. The double Lys-/Cys- mutation abolished completely the Ki-Ras protective effect. Note that the effect of cysteine mutation, albeit small compared with that of the Lys- mutant, was significant and reproducible (Figures 4a and 5a). These findings indicate that the protection from apoptosis by the Ki-Ras isoform was mainly determined by the polybasic region at the COOH terminus. ERK1/2-dependent transcription was not affected in Lys- mutants.19 Determination of ROS in Ki-Ras–transfected cells indicates that low ROS levels parallel resistance to H2O2-induced apoptosis. Moreover, mutation of lysines at the COOH terminus of Ki-Ras significantly increased ROS levels, although Ki-Ras Cys- also showed a partial effect (Figure 4b). These data suggest that susceptibility to H2O2-induced apoptosis is linked to the ability of Ki-Ras to lower ROS levels. Immunoblot with anti–Ki-Ras antibody shows that transfected cells expressed comparable levels of Ras proteins (Figure 4a, inset). Staining of transfected cells with an antibody against the HA tag of the exogenous proteins shows that the Cys- mutation resulted in a significant loss of the canonical plasma membrane signal without significant changes in intracellular dotlike fluorescence (Figure 4c). Conversely, in Lys- Ki-Ras–expressing cells, the dotlike fluorescence disappeared. The double-mutant protein was completely diffuse throughout the cell (Figure 4c). Although the immunofluorescence data shown do not identify the specific intracellular compartment(s) where Ki-Ras mutants are localized, they suggest a major modification in the localization pattern relative to the wild-type gene.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 4. Ki-Ras mutants at the COOH terminus differentially modulate tolerance to oxidative stress. HUVECs were transiently transfected with Ki-Ras–expressing vectors lacking the farnesylation signal (Cys-), the polybasic stretch (Lys-), or both (Cys-/Lys-). a, Percentage of cells undergoing apoptosis (annexin V–cy3) after H2O2 stimulation. Data are mean±SEM. *P<0.05 vs control; **P<0.05 vs wild-type. Inset shows immunoblot with anti–Ki-Ras 4B–specific antibodies (Santa Cruz Biotechnology, C-19). Longer exposures of the film showed the band of the endogenous gene (first lane). b, Time course of ROS production by Fe++ ascorbate (0.1 mmol/L) oxidative stress in Ha-Ras and Ki-Ras wild-type and derivative mutants. HUVECs were transfected as indicated in panel a. Data are mean±SEM. *P<0.05 wild-type Ha-Ras and Ki-Ras vs control; **P<0.05 vs wild-type. c, Confocal microscopy (Leica, Model TCS SP2) of HUVECs transfected with wild-type and mutant HA-tagged Ki-Ras. Exogenous protein was detected by immunofluorescence against the HA tag. Generation of Ki-Ras mutants is described in Methods. Different planes of the cell are shown, above (Cys-) or inside (Cys- and Lys-) the nucleus.



View larger version (35K):
[in this window]
[in a new window]
 
Figure 5. Ki-Ras farnesylation slightly affects tolerance to oxidative stress. a, Control cells and cells expressing Ha-Ras or Ki-Ras wild-type and mutants were subjected to oxidative injury with and without preincubation with the farnesylation inhibitor FTI-277. Diagram represents percentage of annexin V-cy3–positive cells derived from 3 independent experiments by fluorescence microscopy. Data are mean±SEM. We have compared the effects of the wild-type genes vs control (*P<0.05), those of the mutants vs wild-type Ki-Ras (**P<0.05), and those of FTI-277 treatment vs untreated samples ***P<0.05. b, Confocal microscopy photographs of HUVECs transiently transfected with vectors expressing either the Ha-Ras or Ki-Ras COOH-terminal portion (indicated by the box) fused to GFP (broken lines) (see Methods). Experiments were performed in the absence or presence of FTI-277.

How the Ki-Ras Lipid Anchor Contributes to the Protection of Endothelial Cells From H2O2-Induced Apoptosis
The data shown above indicate that the main lipid anchor signal, the cysteine within the CAAX box, does not have a dominant role in the tolerance to H2O2-induced apoptosis in Ki-Ras–expressing cells. To assess independently the role of Ki-Ras CAAX box farnesylation signal in the development of tolerance to oxidative injuries in HUVECs, we used the farnesyl transferase inhibitor, FTI-277, which prevents farnesylation of Ras proteins.20,24 Control cells and Ha-Ras and Ki-Ras wild-type and mutant transfected cells were incubated, before the application of the oxidative stress, with FTI-277 (Figure 5a). This compound significantly inhibited apoptosis in control and Ha-Ras–expressing cells. Conversely, the protective effect of Ki-Ras wild type was only partially affected. Treatment with FTI-277 resulted in a partial stimulation of apoptosis, in cells expressing either Lys- or Cys- Ki-Ras. Figure 5 indicates that FTI-277 treatment does not eliminate the protective effect of Ki-Ras, as does the mutation in the lysine stretch at the COOH terminus. A reproducible effect of FTI-277 treatment can only be detected in Lys- Ki-Ras–expressing cells. FTI-277 has a limited effect on wild-type or Cys- Ki-Ras–expressing cells. Taken together, these data indicate that farnesylation has a minor role in cytoprotection by Ki-Ras.

To test the effect of FTI-277 on the intracellular localization of Ha-Ras and Ki-Ras proteins, we transiently expressed fusion proteins containing the wild-type or mutant COOH termini of Ki-Ras and GFP at the NH2 terminus. GFP in these fusion proteins contains the natural Ki-Ras localization signals (see Methods). The fluorescence staining of FTI-277–pretreated cells indicates that the compound efficiently displaced the GFP-fusion protein carrying the COOH terminus of Ha-Ras. On the other hand, a redistribution of membrane localization, without any significant changes in the intracellular fluorescent dots, was observed in cells expressing the GFP-fusion protein carrying the COOH terminus of Ki-Ras (Figure 5b).

At present we do not know whether the dots shown by the Ki-Ras fluorescent signal indicate a specific membrane subcompartment or a different organelle where Ki-Ras is localized. In both cases, this location appears to be important for the tolerance of oxidative stress by Ki-Ras.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The production of intracellular ROS has been implicated in the pathogenesis of several human disorders (Alzheimer’s and Parkinson’s diseases, cancer, cerebral and myocardial ischemia, atherosclerosis, etc), as well as aging.15 Recent insights into the p21 Ras ERK1/2 signaling cascade suggest that Ras is directly involved in the regulation of the intracellular redox state.8,18,19

HUVECs, exposed to 2 mmol/L H2O2 for 2 hours, undergo apoptosis 6 to 24 hours later. This is accompanied by activation of stress-related kinases that culminates in the apoptotic death of stressed cells. This process is initiated by H2O2, which increases intracellular ROS and triggers Ras activation.8,18 Ras (specifically Ha-Ras) stimulates intracellular ROS levels by activating NADPH oxidase, further amplifying the cascade initiated by H2O2.18,19 Ki-Ras and Ha-Ras regulate H2O2-induced apoptosis in a complementary fashion; Ki-Ras increases the tolerance, whereas Ha-Ras decreases it and promotes apoptosis induced by H2O2. Both Ki-Ras and Ha-Ras effects are dependent on the Ras signaling cascade because the transdominant negative Ras variant Leu61-Ser186 completely suppresses both the Ki- and the Ha- effects (Figure 2). Ras activation of MEK and ERK1/2 signaling is required for stimulation of H2O2-induced apoptosis (Figure 2b) or protection (Figure 3c and 3d). Because these cells express predominantly Ha-Ras, it is likely that inhibition of H2O2-dependent apoptosis by MEK inhibitor PD98059 or farnesyl transferase inhibitor FTI-277 is dependent on ERK1/2 signaling triggered by Ha-Ras (Figure 3c and 3d). On the other hand, cells transfected with Ki-Ras are resistant to H2O2-dependent apoptosis, and they became sensitive when treated with the MEK inhibitor PD98059 (Figure 2b). These data are puzzling, because they indicate that the same enzymatic cascade induces opposing phenotypes in the same cell type (Figures 2b and 3). In fact, there are reports showing that ERK1/2 signaling induces apoptosis13,14 or that ERK1/2 signaling inhibits apoptosis.11,12 The analysis of the available data may shed some light on this apparent paradox. Ha-Ras is an important activator of the NADPH oxidase complex, because it participates in the assembly under the plasma membrane of the oxidase complex18 (Figure 6). The activation of the NADPH oxidase complex results in a significant increase of cellular ROS. ROS can directly activate GTP binding proteins, such as Ras and G proteins.8,25 Taken together, these effects indicate a short amplifying loop involving Ras (specifically Ha-Ras) and ROS. Ha-Ras might work as a direct sensor of ROS by activating stress-related kinases. Inhibition of Ha-Ras eliminates the sensor and the main inducer of ROS, leading to escape of the cell from H2O2-induced apoptosis (Figures 2 and 5). Under physiological conditions, ROS are required for induction of DNA synthesis, and their inhibition severely impairs Ha-Ras–induced DNA synthesis.18 Overactivation of this circuit might severely impair cellular functions and induce the elimination of the cells containing higher ROS levels. The amplification of this pathway would lead to massive apoptosis if not restrained by a complementary activity. Ki-Ras performs this function by reducing cellular ROS and antagonizing Ha-Ras. Ki-Ras effects on ROS are dependent on a polybasic lysine stretch at the COOH terminus and not on the classical farnesylation box that is known to be essential for Ras activity (for review, see Reference 26). We have recently found that Ki-Ras but not Ha-Ras stimulates the mitochondrial enzyme manganese superoxide dismutase (MnSOD) via ERK1/2 signaling and that the polybasic region of Ki-Ras is essential for this induction.19 Taken together, the data suggest that Ki-Ras reduces H2O2–induced apoptosis by buffering the production of endogenous ROS via MnSOD-ERK1/2 signaling (Figure 6). The difference between ERK1/2 activated by Ha-Ras or Ki-Ras is probably accounted for either by a different membrane compartmentalization27, 28 or by a discrete organelle localization encoded by the polybasic lysine stretch.29



View larger version (35K):
[in this window]
[in a new window]
 
Figure 6. Regulation of cellular ROS by Ha-Ras and Ki-Ras. Schematic diagram showing effects of H2O2 treatment on Ras signaling. Oxidative stress initiated by H2O2 may activate directly Ras or GTP binding proteins or increase cellular levels of ROS. Ha-Ras stimulates the activity of the NADPH oxidase complex, which in turn increases ROS levels. Ki-Ras, on the other hand, stimulates powerfully ERK1/2 signaling and activates both transcription and mitochondrial MnSOD, which reduces superoxide anion levels in combination with catalase. This might be accomplished either by a different membrane compartmentalization or by a discrete subcellular localization.

The protective effect of Ki-Ras on H2O2-induced apoptosis is abolished by Ras dominant negative variants and MEK inhibitor, but not by FTI-277 (Figures 2, 3, and 5). This is not surprising, given that Ki-Ras 4B is relatively insensitive to FTIs.30 On the other hand, total ERK1/2 activity in HUVECs is almost totally dependent on Ha-Ras, which is the predominant isoform expressed by these cells (Figure 3a). Thus, PD98095 induces cytoprotection both in Ha-Ras–expressing cells and in control HUVECs. Conversely, cells expressing Ki-Ras are more sensitive to apoptosis when treated with MEK inhibitor. It is likely that overexpression of Ki-Ras masks the activation of ERK driven by the endogenous Ha-Ras gene. Similarly, the antiapoptotic effect of FTIs in HUVECs stressed with H2O2 can be explained by selective inhibition of Ha-Ras.

The data we have presented contain some general implications. In cells or tissues with high Ki-Ras/Ha-Ras ratio, the reduction of ROS by extracellular stimuli is dominant over the production of ROS, and it may result in profound changes in oxidative metabolism. Conversely, endothelial cells, expressing predominantly Ha-Ras (Figure 2), are exquisitely sensitive to oxidative stress. This notion is supported also by recent data showing that activated Ha-Ras, but not Ki-Ras, can induce apoptosis.31

In conclusion, our data highlight a new, modulatory role of the 2 Ras genes in endothelial cell response to oxidative injuries and point to the potential utilization of p21 Ras as an alternative molecular target in disorders associated with high levels of intracellular ROS.


*    Acknowledgments
 
This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro, Targeted Project Biotechnology CNR, and Project Cluster C-04 MURST (Italian Ministry of University and Research). We give special thanks to Drs Giuseppina Ruggiero and Paolo Ricchi for help with FACS analysis and to Prof Maria Pavia for help with statistical analysis.


*    Footnotes
 
*Both authors contributed equally to this study. Back

Received July 31, 2001; revision received December 10, 2001; accepted December 21, 2001.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Giasson BI, Duda JE, Murray IV, et al. Oxidative damage linked to neurodegeneration by selective {alpha}-synuclein nitration in synucleinopathy lesions. Science. 2000; 290: 985–989.

2. Prasad KN, Cole WC, Hovland AR, et al. Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale. Clin Neuropharmacol. 2000; 23: 2–13.

3. Cleveland JL, Kastan MB. Cancer: a radical approach to treatment. Nature. 2000; 407: 309–311.

4. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res. 2000; 87: 179–183.

5. Johnson FB, Sinclair DA, Guarente L. Molecular biology of aging. Cell. 1999; 96: 291–302.

6. Bar-Sagi D, Hall A. Ras, and Rho GTPases: a family reunion. Cell. 2000; 103: 227–238.

7. Pennisi E. Superoxides relay Ras protein’s oncogenic message. Science. 1997; 275: 1567–1568.

8. Lander HM, Milbank AJ, Tauras JM, et al. Redox regulation of cell signalling. Nature. 1996; 381: 380–381.

9. Halfon MS, Carmena A, Gisselbrecht S, et al. Ras pathway specificity is determined by the integration of multiple signal-activated and tissue-restricted transcription factors. Cell. 2000; 103: 63–74.

10. Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995; 270: 1326–1331.

11. Stadheim TA, Xiao H, Eastman A. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells. Cancer Res. 2001; 61: 1533–1540.

12. Mitsui H, Takuwa N, Maruyama T, et al. The MEK1-ERK map kinase pathway and the PI 3-kinase-Akt pathway independently mediate anti-apoptotic signals in HepG2 liver cancer cells. Int J Cancer. 2001; 92: 55–62.

13. Kim M, So H, Park J, et al. Hwansodan protects PC12 cells against serum-deprivation-induced apoptosis via a mechanism involving Ras and mitogen-activated protein (MAP) kinase pathway. Gen Pharmacol. 2000; 34: 227–235.

14. She QB, Bode AM, Ma WY, et al. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 2001; 61: 1604–1610.

15. Glomset JA, Farnsworth CC. Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes. Annu Rev Cell Biol. 1994; 10: 181–205.

16. Yan Z, Chen M, Perucho M, et al. Oncogenic Ki-ras but not oncogenic Ha-ras blocks integrin ß1-chain maturation in colon epithelial cells. J Biol Chem. 1997; 272: 30928–30936.

17. Johnson L, Greenbaum D, Cichowski K, et al. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 1997; 11: 2468–2481.

18. Irani K, Xia Y, Zweier JL, et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 1997; 275: 1649–1652.

19. Santillo M, Mondola P, Serù P, et al. Opposing functions of Ki- and Ha-Ras genes in the regulation of redox signals. Curr Biol. 2001; 11: 614–619.

20. Medema RH, Wubbolts R, Bos JL. Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression. Mol Cell Biol. 1991; 11: 5963–5967.

21. Higuchi M, Honda T, Proske RJ, et al. Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene. 1998; 17: 2753–2760.

22. Stacey DW, Feig LA, Gibbs JB. Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Mol Cell Biol. 1991; 11: 4053–4064.

23. Kultz D, Madhany S, Burg MB. Hyperosmolality causes growth arrest of murine kidney cells: induction of GADD45 and GADD153 by osmosensing via stress-activated protein kinase 2. J Biol Chem. 1998; 273: 13645–13651.

24. Lerner EC, Qian Y, Blaskovich MA, et al. Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J Biol Chem. 1995; 270: 26802–26806.

25. Nishida M, Maruyama Y, Tanaka R. G {alpha}(i), and G {alpha}(o) are target proteins of reactive oxygen species. Nature. 2000; 408: 492–495.

26. Magee T, Marshall C. New insights into the interaction of Ras with the plasma membrane. Cell. 1999; 98: 9–11.

27. Choy E, Chiu VK, Silletti J, et al. Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell. 1999; 98: 69–80.

28. Prior IA, Harding A, Jan J, et al. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat Cell Biol. 2000; 3: 368–377.

29. Rebollo A, Perez-Sala D, Martinez-A C. Bcl-2 differentially targets K-, N-, and H-Ras to mitochondria in IL-2 supplemented or deprived cells: implications in prevention of apoptosis. Oncogene. 1999; 18: 4930–4939.

30. James GL, Goldstein JL, Brown MS. Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro. J Biol Chem. 1995; 270: 6221–6226.

31. Walsh AB, Bar-Sagi D. Differential activation of the Rac pathway by Ha-Ras and K-Ras. J Biol Chem. 2001; 276: 15609–15615.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. V. Sangle, R. Zhao, and G. X. Shen
Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1243 - E1254.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L.-J. Min, M. Mogi, J. Iwanami, J.-M. Li, A. Sakata, T. Fujita, K. Tsukuda, M. Iwai, and M. Horiuchi
Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence
Cardiovasc Res, December 1, 2007; 76(3): 506 - 516.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Sabbatini, M. Santillo, A. Pisani, R. Paterno, F. Uccello, R. Seru, G. Matrone, G. Spagnuolo, M. Andreucci, V. Serio, et al.
Inhibition of Ras/ERK1/2 signaling protects against postischemic renal injury
Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1408 - F1415.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Svegliati, R. Cancello, P. Sambo, M. Luchetti, P. Paroncini, G. Orlandini, G. Discepoli, R. Paterno, M. Santillo, C. Cuozzo, et al.
Platelet-derived Growth Factor and Reactive Oxygen Species (ROS) Regulate Ras Protein Levels in Primary Human Fibroblasts via ERK1/2: AMPLIFICATION OF ROS AND Ras IN SYSTEMIC SCLEROSIS FIBROBLASTS
J. Biol. Chem., October 28, 2005; 280(43): 36474 - 36482.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Murakami, H. Takagi, K. Suzuma, I. Suzuma, H. Ohashi, D. Watanabe, T. Ojima, E. Suganami, M. Kurimoto, H. Kaneto, et al.
Angiopoietin-1 Attenuates H2O2-induced SEK1/JNK Phosphorylation through the Phosphatidylinositol 3-Kinase/Akt Pathway in Vascular Endothelial Cells
J. Biol. Chem., September 9, 2005; 280(36): 31841 - 31849.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. Valle, A. Alvarez-Barrientos, E. Arza, S. Lamas, and M. Monsalve
PGC-1{alpha} regulates the mitochondrial antioxidant defense system in vascular endothelial cells
Cardiovasc Res, June 1, 2005; 66(3): 562 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-J. Na, S.-J. Lee, Y.-C. Kang, Y.-L. Cho, W.-D. Nam, P. K. M. Kim, K.-S. Ha, H.-T. Chung, H. Lee, Y.-G. Kwon, et al.
Inhibition of Farnesyltransferase Prevents Collagen-Induced Arthritis by Down-Regulation of Inflammatory Gene Expression through Suppression of p21ras-Dependent NF-{kappa}B Activation
J. Immunol., July 15, 2004; 173(2): 1276 - 1283.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Wong, C. Hull, R. Zhande, J. Law, and A. Karsan
Lipopolysaccharide initiates a TRAF6-mediated endothelial survival signal
Blood, June 15, 2004; 103(12): 4520 - 4526.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Sabbatini, A. Pisani, F. Uccello, V. Serio, R. Seru, R. Paterno, B. Cianciaruso, G. Fuiano, and M. Andreucci
Atorvastatin Improves the Course of Ischemic Acute Renal Failure in Aging Rats
J. Am. Soc. Nephrol., April 1, 2004; 15(4): 901 - 909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. S. Powell, M. M. Wright, and R. M. Jackson
p38mapk and MEK1/2 inhibition contribute to cellular oxidant injury after hypoxia
Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L826 - L833.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. A. Kowluru, A. Kowluru, S. Chakrabarti, and Z. Khan
Potential Contributory Role of H-Ras, a Small G-Protein, in the Development of Retinopathy in Diabetic Rats
Diabetes, March 1, 2004; 53(3): 775 - 783.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. L. Starcevic, N. M. Diotte, K. L. Zukowski, M. J. Cameron, and R. F. Novak
Oxidative DNA Damage and Repair in a Cell Lineage Model of Human Proliferative Breast Disease (PBD)
Toxicol. Sci., September 1, 2003; 75(1): 74 - 81.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Ricchi, A. D. Palma, T. D. Matola, A. Apicella, R. Fortunato, R. Zarrilli, and A. M. Acquaviva
Aspirin Protects Caco-2 Cells from Apoptosis after Serum Deprivation through the Activation of a Phosphatidylinositol 3-Kinase/AKT/p21Cip/WAF1Pathway
Mol. Pharmacol., August 1, 2003; 64(2): 407 - 414.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Rafiee, C. P. Johnson, M. S. Li, H. Ogawa, J. Heidemann, P. J. Fisher, T. H. Lamirand, M. F. Otterson, K. T. Wilson, and D. G. Binion
Cyclosporine A Enhances Leukocyte Binding by Human Intestinal Microvascular Endothelial Cells through Inhibition of p38 MAPK and iNOS. PARADOXICAL PROINFLAMMATORY EFFECT ON THE MICROVASCULAR ENDOTHELIUM
J. Biol. Chem., September 13, 2002; 277(38): 35605 - 35615.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/8/968    most recent
hc0802.104324v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cuda, G.
Right arrow Articles by Avvedimento, E. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cuda, G.
Right arrow Articles by Avvedimento, E. V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-METHIONINE
*HYDROGEN PEROXIDE
Related Collections
Right arrow Oxidant stress